-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Minimed Group with Overweight Rating, Announces Price Target of $26

Benzinga·04/01/2026 13:48:40
Listen to the news
Barclays analyst Matt Miksic initiates coverage on Minimed Group (NASDAQ:MMED) with a Overweight rating and announces Price Target of $26.